Factory Supply QSC Tirzepatide CAS 2023788-19-2 High Purity Peptide

QSC Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates significantly enhanced efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.

The qsc tirzepatide molecule exhibits greater affinity for GIP receptors while maintaining potent GLP-1 receptor activity. This unique dual mechanism has shown superior hyperglycemia reduction in research settings. The compound mimics natural GIP action at GIP receptors while delivering enhanced metabolic effects.

As a research compound, qsc tirzepatide represents an important advancement in metabolic disorder studies. The white powder formulation maintains stability when stored properly, with shelf life exceeding two years under recommended conditions. Researchers value this compound for its consistent purity and reproducible results in experimental models.

Our qsc tirzepatide is produced under strict quality control measures to ensure batch-to-batch consistency. The pharmaceutical grade material is ideal for investigative studies examining glucose metabolism, weight management, and related metabolic pathways.